As of 2026-02-18, the Relative Valuation of Hikma Pharmaceuticals PLC (HIK.L) is 3,395.06 GBP. This relative valuation is based on P/E multiples. With the latest stock price at 1,600.00 GBP, the upside of Hikma Pharmaceuticals PLC based on Relative Valuation is 112.2%.
The range of the Relative Valuation is 2,289.35 - 3,958.66 GBP.
| Range | Selected | |
| Trailing P/E multiples | 18.2x - 31.5x | 24.8x |
| Forward P/E multiples | 24.0x - 31.3x | 29.2x |
| Fair Price | 2,289.35 - 3,958.66 | 3,395.06 |
| Upside | 43.1% - 147.4% | 112.2% |
| Date | P/E |
| 2026-02-17 | 12.72 |
| 2026-02-16 | 12.56 |
| 2026-02-13 | 12.57 |
| 2026-02-12 | 12.57 |
| 2026-02-11 | 12.39 |
| 2026-02-10 | 12.37 |
| 2026-02-09 | 12.29 |
| 2026-02-06 | 12.24 |
| 2026-02-05 | 12.43 |
| 2026-02-04 | 13.29 |
| 2026-02-03 | 12.41 |
| 2026-02-02 | 12.37 |
| 2026-01-30 | 12.20 |
| 2026-01-29 | 12.12 |
| 2026-01-28 | 12.24 |
| 2026-01-27 | 12.40 |
| 2026-01-26 | 12.44 |
| 2026-01-23 | 12.37 |
| 2026-01-22 | 12.37 |
| 2026-01-21 | 12.11 |
| 2026-01-20 | 12.17 |
| 2026-01-19 | 12.29 |
| 2026-01-16 | 12.55 |
| 2026-01-15 | 12.48 |
| 2026-01-14 | 12.41 |
| 2026-01-13 | 12.21 |
| 2026-01-12 | 12.41 |
| 2026-01-09 | 12.52 |
| 2026-01-08 | 12.30 |
| 2026-01-07 | 12.41 |
| 2026-01-06 | 12.57 |
| 2026-01-05 | 12.16 |
| 2026-01-02 | 12.13 |
| 2025-12-31 | 12.38 |
| 2025-12-30 | 12.31 |
| 2025-12-29 | 12.24 |
| 2025-12-24 | 12.16 |
| 2025-12-23 | 12.18 |
| 2025-12-22 | 12.09 |
| 2025-12-19 | 12.03 |
| 2025-12-18 | 12.03 |
| 2025-12-17 | 12.06 |
| 2025-12-16 | 11.99 |
| 2025-12-15 | 11.99 |
| 2025-12-12 | 12.13 |
| 2025-12-11 | 12.18 |
| 2025-12-10 | 12.22 |
| 2025-12-09 | 12.38 |
| 2025-12-08 | 12.51 |
| 2025-12-05 | 12.73 |